Poster exhibition
Virus infections and the immunocompromised host

Programme

• • Poster
  • P 180

  Dynamics of chronic hepatitis E virus variant evolution during ribavirin treatment: An in-depth in vitro versus in vivo comparison

  • Dominik Harms (Berlin / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 181

  Using intestinal organoids to study the stem cell niche as a potential reservoir for hepatitis E virus infections

  • Sarah Prallet (Heildeberg / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 182

  Oral HPV infections over time after transplantation: Prevalence and risk factors in recipients recruited for the DZIF Transplant Cohort in Southern Germany

  • Nele Fries (Tuebingen / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 183

  Immunosuppressive functions of the HCMV glycoprotein UL11

  • Maria Camila Ramirez (Hannover / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 184

  Analysis of the immune response against the cytomegalovirus gHgLgO glycoprotein complex

  • Lena Thiessen (München / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 185

  Unmasking immunosuppressive regimes as a driver of virus evolution: Mycophenolic acid and the path to enhanced viral pathogenesis

  • Dr. Toni Luise Meister (Bochum / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 186

  From sequences to consequences: A longitudinal analysis of within-host Hepatitis E viral evolution in a chronically infected, immunocompromised patient

  • Johanna Kleine (Freiburg / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 187

  Plasma from elite-neutralizing blood donors can increase the neutralization capacity against human cytomegalovirus in hematopoietic stem cell recipients

  • Professor Christian Sinzger (Ulm / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 188

  Torque teno virus load is associated with CDC stage and CD4+ cell count in people living with HIV but unrelated to AIDS-defining events and human pegivirus load

  • Dr. Martin Pirkl (Cologne / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 189

  Analysis of quasispecies evolution of JC-Polyomavirus from patients with PML

  • David Meierkord (Düsseldorf / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 190

  Characterizing immunological non-responders in HIV patients: insights into T cell dynamics, cytokine responses, and novel biomarkers

  • Dr. Niklas Floß (Essen / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 192

  Antiviral strategies of interferons to control intestinal adenoviral infection

  • Lisa Hanrieder (Munich / DE)

   Virus infections and the immunocompromised host
• • Poster
  • P 193

  CMV in transplant recipients – Identifying patients at high risk for complicated-to-treat CMV infections and combined therapy approach

  • Dr. Veronica Di Cristanziano (Cologne / DE)
  • Moritz Trappe (Köln / DE)
  • Dr. Rolf Kaiser (Cologne / DE)

   Virus infections and the immunocompromised host